These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36185276)

  • 101. Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment.
    Kumar R; Gupta R
    Front Oncol; 2024; 14():1456631. PubMed ID: 39161385
    [TBL] [Abstract][Full Text] [Related]  

  • 102. IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway.
    Li Y; Li Y; Xiang B; Tian X; Shi Q; Liu F; Lin T; Wei G
    J Oncol; 2022; 2022():4544773. PubMed ID: 36213822
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Chronic In Vivo Interaction of Dendritic Cells Expressing the Ligand Rae-1ε with NK Cells Impacts NKG2D Expression and Function.
    Morvan MG; Champsaur M; Reizis B; Lanier LL
    Immunohorizons; 2017 May; 1(3):10-19. PubMed ID: 28815225
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy.
    Wu B; Tapadar S; Ruan Z; Sun C; Arnold R; Johnston A; Olugbami J; Arunsi U; Gaul D; Petros J; Kobayashi T; Duda DG; Oyelere AK
    bioRxiv; 2024 Jun; ():. PubMed ID: 38585757
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg.
    Fernández-Barrena MG; Arechederra M; Colyn L; Berasain C; Avila MA
    JHEP Rep; 2020 Dec; 2(6):100167. PubMed ID: 33134907
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Fluid shear stress enhances natural killer cell's cytotoxicity toward circulating tumor cells through NKG2D-mediated mechanosensing.
    Hu B; Xin Y; Hu G; Li K; Tan Y
    APL Bioeng; 2023 Sep; 7(3):036108. PubMed ID: 37575881
    [TBL] [Abstract][Full Text] [Related]  

  • 107. ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome.
    Easom NJW; Marks M; Jobe D; Gillmore R; Meyer T; Maini MK; Njie R
    Front Oncol; 2020; 10():971. PubMed ID: 32656081
    [TBL] [Abstract][Full Text] [Related]  

  • 108. NKG2D Fine-Tunes the Local Inflammatory Response in Colorectal Cancer.
    Curio S; Lin W; Bromley C; McGovern J; Triulzi C; Jonsson G; Ghislat G; Zelenay S; Guerra N
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980678
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The efficacy and safety of chidamide in combination with etoposide and glucocorticoids for the treatment of hemophagocytic lymphohistiocytosis in adult patients: an open-label, single-center study.
    Hu J; Wang J; Wang Z
    Front Immunol; 2024; 15():1415597. PubMed ID: 39040100
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition.
    Han R; Ling C; Wang Y; Lu L
    Cancer Cell Int; 2023 Sep; 23(1):203. PubMed ID: 37716965
    [TBL] [Abstract][Full Text] [Related]  

  • 111. HDAC-an important target for improving tumor radiotherapy resistance.
    Ling R; Wang J; Fang Y; Yu Y; Su Y; Sun W; Li X; Tang X
    Front Oncol; 2023; 13():1193637. PubMed ID: 37503317
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Radiation-induced tumor immune microenvironments and potential targets for combination therapy.
    Guo S; Yao Y; Tang Y; Xin Z; Wu D; Ni C; Huang J; Wei Q; Zhang T
    Signal Transduct Target Ther; 2023 May; 8(1):205. PubMed ID: 37208386
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Inhibition of miR-20a by pterostilbene facilitates prostate cancer cells killed by NK cells via up-regulation of NKG2D ligands and TGF-β1down-regulation.
    Youlin K; Simin L; Jian K; Li Z
    Heliyon; 2023 Apr; 9(4):e14957. PubMed ID: 37064475
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
    Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA
    Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
    Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
    Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Leveraging NKG2D Ligands in Immuno-Oncology.
    Fuertes MB; Domaica CI; Zwirner NW
    Front Immunol; 2021; 12():713158. PubMed ID: 34394116
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma.
    Liu YF; Chiang Y; Hsu FM; Tsai CL; Cheng JC
    Front Oncol; 2022; 12():1009089. PubMed ID: 36185276
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation.
    Son CH; Keum JH; Yang K; Nam J; Kim MJ; Kim SH; Kang CD; Oh SO; Kim CD; Park YS; Bae J
    Radiat Oncol; 2014 Feb; 9():49. PubMed ID: 24512718
    [TBL] [Abstract][Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.